Management of Normal Flow, Low Gradient Aortic Stenosis

Study Questions:

Do patients with normal flow, low gradient (NF-LG) severe aortic stenosis (AS) benefit from intervention?

Methods:

This retrospective study examined 303 patients with severe symptomatic NF-LG severe AS from a single center (from a total population of 1,358 with severe AS) and compared outcomes between patients treated conservatively (n = 149) versus those undergoing transcatheter aortic valve replacement (TAVR) (n = 114) or surgical aortic valve replacement (SAVR) (n = 40).

Results:

With a mean follow-up of 652 days, 60 deaths occurred. In patients treated conservatively versus treated with TAVR or SAVR, mortality was 28%, 10%, and 12%, respectively (p < 0.001). After multivariable adjustment, TAVR was associated with reduced mortality (hazard ratio [HR], 0.5; 95% confidence interval [CI], 0.3-0.9; p = 0.03) and lower cardiac mortality (HR, 0.3; 95% CI, 0.1-0.7; p = 0.01); no differences were observed between TAVR and SAVR. After propensity score matching, there were 94 individuals treated conservatively and 94 individuals treated with TAVR; TAVR was associated with reduced mortality (HR, 0.4; 95% CI, 0.2-0.9; p = 0.03).

Conclusions:

Patients with symptomatic NF-LG severe AS treated with TAVR had lower mortality compared to individuals treated conservatively.

Perspective:

Patients with NF-LG severe AS are a challenging cohort to manage, as they do not fit into current guideline recommendations for valve replacement, and yet may have symptoms consistent with AS. While underestimation of gradients on echocardiography can incorrectly suggest this category, NF-LG severe AS is also frequently seen on invasive hemodynamics and is clearly a common patient cohort. This study finds that patients assigned to conservative management by their cardiologist or selected by personal preference have markedly higher rates of mortality even after adjusting for other variables. However, there may be unmeasured variables playing a role in these differences. Among this population that did not meet guideline recommendations for valve replacement, it is not clear why nearly one half were treated with an intervention. These findings support the need for randomized trials to evaluate the role of valve replacement in patients with NF-LG severe AS.

Keywords: Aortic Valve Stenosis, Cardiac Surgical Procedures, Cardiology Interventions, Diagnostic Imaging, Echocardiography, Heart Valve Diseases, Heart Valve Prosthesis, Hemodynamics, Transcatheter Aortic Valve Replacement


< Back to Listings